{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:01:23Z","timestamp":1762956083946,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T00:00:00Z","timestamp":1554163200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12872-019-1046-y","type":"journal-article","created":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T08:03:05Z","timestamp":1554192185000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The safety of antithrombotic therapy in patients with cerebral microbleeds and cardiogenic cerebral embolism due to nonvalvular atrial fibrillation"],"prefix":"10.1186","volume":"19","author":[{"given":"Jiayu","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3322-6519","authenticated-orcid":false,"given":"Xiaowei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,2]]},"reference":[{"key":"1046_CR1","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jval.2014.10.012","volume":"18","author":"S Cope","year":"2015","unstructured":"Cope S, Clemens A, Hammes F, et al. Critical appraisal of network meta-analyses evaluating the efficacy and safety of new oral anticoagulants in atrial fibrillation stroke prevention trials. Value Health. 2015;18:234\u201349. \n                    https:\/\/doi.org\/10.1016\/j.jval.2014.10.012\n                    \n                  .","journal-title":"Value Health"},{"key":"1046_CR2","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1161\/STROKEAHA.111.626853","volume":"43","author":"YO Soo","year":"2012","unstructured":"Soo YO, Siu DY, Abrigo J, et al. Risk of intracerebral hemorrhage in patients with cerebral microbleeds undergoing endovascular intervention. Stroke. 2012;43:1532\u20136. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.111.626853\n                    \n                  .","journal-title":"Stroke"},{"key":"1046_CR3","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.1161\/STROKEAHA.110.595181","volume":"41","author":"MM Poels","year":"2010","unstructured":"Poels MM, Vernooij MW, Ikram MA, et al. Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study. Stroke. 2010;41:S103\u20136. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.110.595181\n                    \n                  .","journal-title":"Stroke"},{"key":"1046_CR4","doi-asserted-by":"publisher","first-page":"216","DOI":"10.4103\/0976-3147.203836","volume":"8","author":"A Potigumjon","year":"2017","unstructured":"Potigumjon A, Watcharakorn A, Dharmasaroja PA. Prevalence of cerebral microbleeds in Thai patients with ischemic stroke. J Neurosci Rural Pract. 2017;8:216\u201320. \n                    https:\/\/doi.org\/10.4103\/0976-3147.203836\n                    \n                  .","journal-title":"J Neurosci Rural Pract"},{"key":"1046_CR5","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1161\/STROKEAHA.111.000038","volume":"44","author":"A Charidimou","year":"2013","unstructured":"Charidimou A, Kakar P, Fox Z, et al. Cerebral microbleeds and recurrent stroke risk: systematic review and meta-analysis of prospective ischemic stroke and transient ischemic attack cohorts. Stroke. 2013;44:995\u20131001. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.111.000038\n                    \n                  .","journal-title":"Stroke."},{"key":"1046_CR6","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.01.005","volume":"23","author":"T Saito","year":"2014","unstructured":"Saito T, Kawamura Y, Tanabe Y, et al. Cerebral microbleeds and asymptomatic cerebral infarctions in patients with atrial fibrillation. J Stroke Cerebrovasc Dis. 2014;23:1616\u201322. \n                    https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2014.01.005\n                    \n                  .","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1046_CR7","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s00415-015-7966-2","volume":"263","author":"S Haji","year":"2016","unstructured":"Haji S, Planchard R, Zubair A, et al. The clinical relevance of cerebral microbleeds in patients with cerebral ischemia and atrial fibrillation. J Neurol. 2016;263:238\u201344. \n                    https:\/\/doi.org\/10.1007\/s00415-015-7966-2\n                    \n                  .","journal-title":"J Neurol"},{"key":"1046_CR8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3389\/fneur.2016.00151","volume":"7","author":"C Karayiannis","year":"2016","unstructured":"Karayiannis C, Soufan C, Chandra RV, et al. Prevalence of brain MRI markers of hemorrhagic risk in patients with stroke and atrial fibrillation. Front Neurol. 2016;7:151. \n                    https:\/\/doi.org\/10.3389\/fneur.2016.00151\n                    \n                  .","journal-title":"Front Neurol"},{"key":"1046_CR9","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1212\/WNL.0000000000000862","volume":"83","author":"TJ Song","year":"2014","unstructured":"Song TJ, Kim J, Song D, et al. Association of cerebral microbleeds with mortality in stroke patients having atrial fibrillation. Neurology. 2014;83:1308\u201315. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000000862\n                    \n                  .","journal-title":"Neurology."},{"key":"1046_CR10","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","volume":"49","author":"WJ Powers","year":"2018","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 guidelines for the early Management of Patients with Acute Ischemic Stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2018;49:e46\u2013e110. \n                    https:\/\/doi.org\/10.1161\/STR.0000000000000158\n                    \n                  .","journal-title":"Stroke."},{"key":"1046_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","volume":"24","author":"HP Adams Jr","year":"1993","unstructured":"Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of org 10172 in acute stroke treatment. Stroke. 1993;24:35\u201341.","journal-title":"Stroke."},{"key":"1046_CR12","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1212\/WNL.43.5.1021","volume":"43","author":"DL Gordon","year":"1993","unstructured":"Gordon DL, Bendixen BH, Adams HP Jr, et al. Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke: implications for clinical trials. The TOAST investigators. Neurology. 1993;43:1021\u20137.","journal-title":"Neurology."},{"key":"1046_CR13","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.07.006","volume":"23","author":"M Schrag","year":"2014","unstructured":"Schrag M, Greer DM. Clinical associations of cerebral microbleeds on magnetic resonance neuroimaging. J Stroke Cerebrovasc Dis. 2014;23:2489\u201397. \n                    https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2014.07.006\n                    \n                  .","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1046_CR14","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893\u2013962. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehw210\n                    \n                  .","journal-title":"Eur Heart J"},{"key":"1046_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1159\/000073894","volume":"17","author":"P Appelros","year":"2004","unstructured":"Appelros P, Terent A. Characteristics of the National Institute of health stroke scale: results from a population-based stroke cohort at baseline and after one year. Cerebrovasc Dis. 2004;17:21\u20137. \n                    https:\/\/doi.org\/10.1159\/000073894\n                    \n                  .","journal-title":"Cerebrovasc Dis"},{"key":"1046_CR16","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1159\/000336240","volume":"33","author":"PC Okubo","year":"2012","unstructured":"Okubo PC, Fabio SR, Domenis DR, et al. Using the National Institute of health stroke scale to predict dysphagia in acute ischemic stroke. Cerebrovasc Dis. 2012;33:501\u20137. \n                    https:\/\/doi.org\/10.1159\/000336240\n                    \n                  .","journal-title":"Cerebrovasc Dis"},{"key":"1046_CR17","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1136\/heartjnl-2013-304347","volume":"100","author":"A Dogliotti","year":"2014","unstructured":"Dogliotti A, Paolasso E, Giugliano RP. Current and new oral antithrombotics in non-valvular atrial fibrillation: a network meta-analysis of 79 808 patients. Heart. 2014;100:396\u2013405. \n                    https:\/\/doi.org\/10.1136\/heartjnl-2013-304347\n                    \n                  .","journal-title":"Heart."},{"key":"1046_CR18","first-page":"5","volume":"9","author":"A Arauz","year":"2017","unstructured":"Arauz A, Ruiz-Navarro F, Barboza MA, et al. Outcome, recurrence and mortality after non-Valvular atrial fibrillation stroke: long-term follow-up study. J Vasc Interv Neurol. 2017;9:5\u201311.","journal-title":"J Vasc Interv Neurol"},{"key":"1046_CR19","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1161\/STROKEAHA.112.652065","volume":"43","author":"D Dowlatshahi","year":"2012","unstructured":"Dowlatshahi D, Butcher KS, Asdaghi N, et al. Poor prognosis in warfarin-associated intracranial hemorrhage despite anticoagulation reversal. Stroke. 2012;43:1812\u20137. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.112.652065\n                    \n                  .","journal-title":"Stroke."},{"key":"1046_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ahj.2014.06.005","volume":"168","author":"S Goto","year":"2014","unstructured":"Goto S, Zhu J, Liu L, et al. Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: a subanalysis of the Apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial. Am Heart J. 2014;168:303\u20139. \n                    https:\/\/doi.org\/10.1016\/j.ahj.2014.06.005\n                    \n                  .","journal-title":"Am Heart J"},{"key":"1046_CR21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.5853\/jos.2016.00360","volume":"18","author":"BJ Kim","year":"2016","unstructured":"Kim BJ, Yoon Y, Sohn H, et al. Difference in the location and risk factors of cerebral microbleeds according to ischemic stroke subtypes. J Stroke. 2016;18:297\u2013303. \n                    https:\/\/doi.org\/10.5853\/jos.2016.00360\n                    \n                  .","journal-title":"J Stroke"},{"key":"1046_CR22","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1161\/01.STR.0000199847.96188.12","volume":"37","author":"A Viswanathan","year":"2006","unstructured":"Viswanathan A, Chabriat H. Cerebral microhemorrhage. Stroke. 2006;37:550\u20135. \n                    https:\/\/doi.org\/10.1161\/01.STR.0000199847.96188.12\n                    \n                  .","journal-title":"Stroke."},{"key":"1046_CR23","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1161\/STROKEAHA.109.558049","volume":"40","author":"J Staals","year":"2009","unstructured":"Staals J, van Oostenbrugge RJ, Knottnerus IL, et al. Brain microbleeds relate to higher ambulatory blood pressure levels in first-ever lacunar stroke patients. Stroke. 2009;40:3264\u20138. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.109.558049\n                    \n                  .","journal-title":"Stroke."},{"key":"1046_CR24","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000250","volume":"2","author":"DE Singer","year":"2013","unstructured":"Singer DE, Chang Y, Borowsky LH, et al. A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score. J Am Heart Assoc. 2013;2:e000250. \n                    https:\/\/doi.org\/10.1161\/JAHA.113.000250\n                    \n                  .","journal-title":"J Am Heart Assoc"},{"key":"1046_CR25","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.08.003","volume":"22","author":"T Imaizumi","year":"2013","unstructured":"Imaizumi T, Inamura S, Kohama I, et al. Antithrombotic drug uses and deep intracerebral hemorrhages in stroke patients with deep cerebral microbleeds. J Stroke Cerebrovasc Dis. 2013;22:869\u201375. \n                    https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2012.08.003\n                    \n                  .","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1046_CR26","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1212\/WNL.0b013e3181eee40f","volume":"75","author":"A Biffi","year":"2010","unstructured":"Biffi A, Halpin A, Towfighi A, et al. Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy. Neurology. 2010;75:693\u20138. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e3181eee40f\n                    \n                  .","journal-title":"Neurology."},{"key":"1046_CR27","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.03.027","volume":"23","author":"K Yamashiro","year":"2014","unstructured":"Yamashiro K, Tanaka R, Okuma Y, et al. Associations of durations of antiplatelet use and vascular risk factors with the presence of cerebral microbleeds. J Stroke Cerebrovasc Dis. 2014;23:433\u201340. \n                    https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2013.03.027\n                    \n                  .","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1046_CR28","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jns.2012.05.017","volume":"319","author":"CK Kim","year":"2012","unstructured":"Kim CK, Kwon HT, Kwon HM. No significant association of aspirin use with cerebral microbleeds in the asymptomatic elderly. J Neurol Sci. 2012;319:56\u20138. \n                    https:\/\/doi.org\/10.1016\/j.jns.2012.05.017\n                    \n                  .","journal-title":"J Neurol Sci"},{"key":"1046_CR29","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1161\/STROKEAHA.114.006448","volume":"45","author":"S Dannenberg","year":"2014","unstructured":"Dannenberg S, Scheitz JF, Rozanski M, et al. Number of cerebral microbleeds and risk of intracerebral hemorrhage after intravenous thrombolysis. Stroke. 2014;45:2900\u20135. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.114.006448\n                    \n                  .","journal-title":"Stroke."},{"key":"1046_CR30","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.02.018","volume":"24","author":"T Saito","year":"2015","unstructured":"Saito T, Kawamura Y, Sato N, et al. Non-vitamin k antagonist oral anticoagulants do not increase cerebral microbleeds. J Stroke Cerebrovasc Dis. 2015;24:1373\u20137. \n                    https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2015.02.018\n                    \n                  .","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1046_CR31","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1055\/s-0038-1627454","volume":"118","author":"L Poli","year":"2018","unstructured":"Poli L, Grassi M, Zedde M, et al. Anticoagulants resumption after warfarin-related intracerebral Haemorrhage: the multicenter study on cerebral hemorrhage in Italy (MUCH-Italy). Thromb Haemost. 2018;118:572\u201380. \n                    https:\/\/doi.org\/10.1055\/s-0038-1627454\n                    \n                  .","journal-title":"Thromb Haemost"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-019-1046-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-019-1046-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-019-1046-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T23:09:03Z","timestamp":1585696143000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-019-1046-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,2]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1046"],"URL":"https:\/\/doi.org\/10.1186\/s12872-019-1046-y","relation":{},"ISSN":["1471-2261"],"issn-type":[{"type":"electronic","value":"1471-2261"}],"subject":[],"published":{"date-parts":[[2019,4,2]]},"assertion":[{"value":"20 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol conforms to the ethical guidelines of the Declaration of Helsinki and was approved by the Ethics Committee of the Beijing Tiantan Hospital. The methods were strictly carried out in accordance with the approved guidelines. Informed consent was obtained from all participants or guardians if they were disturbance of consciousness.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable as it is only relevant for Case Reports.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"77"}}